A cumulative dose safety and tolerability crossover study of arformoterol tartrate inhalation solution and levalbuterol hydrochloride [levosalbutamol] inhalation solution in pediatric subjects (aged 2 to 11 years of age) with asthma.
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2012
At a glance
- Drugs Arformoterol; Levosalbutamol
- Indications Asthma
- Focus Adverse reactions
- 01 Aug 2011 Results published in Pediatric Pulmonology.
- 12 Feb 2010 Actual patient number (53) added as reported by ClinicalTrials.gov.
- 02 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History